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1. ABSTRACT 
 
Background: The aim of this study was to clarify the effect of age on the association 
between body mass index (BMI) and all-cause mortality. 
Methods: A total of 43,972 men and women (aged 40-79 years) completed a 
self-administered questionnaire in 1994.  I followed up the participants from January 1, 
1995 through March 31, 2008, during which 6,694 men and women died.  Cox 
proportional-hazards regression analysis was used to estimate hazard ratios (HRs) and their 
95% confidence intervals (CIs) for all-causes mortality according to the following BMI 
categories: BMI<18.5 (underweight), 18.5-20.9, 21.0-22.9, 23.0-24.9 (reference), 25.0-27.4, 
27.5-29.9, and ≥30.0 kg/m² (obese).  Analyses were stratified according to whether subjects 
were middle-aged (40-64 years) or elderly (65-79 years). 
Results: In men, I observed a significantly increased excess risk of mortality in the 
underweight elderly; multivariate HR was 1.21 (0.90-1.63) for middle-aged and 1.53 
(1.31-1.79) for elderly.  A significantly increased excess risk of mortality was also evident in 
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the obese middle-aged; multivariate HR was 1.65 (1.17-2.34) for middle-aged and 1.13 
(0.80-1.59) for elderly.  In women, I observed an increased excess risk of mortality, 
irrespective of age group, in the underweight; multivariate HR was 1.32 (0.89-1.97) for 
middle-aged and 1.34 (1.10-1.64) for elderly.  An increased excess risk of mortality was also 
evident in the obese, irrespective of age group; multivariate HR was 1.22 (0.79-1.86) for 
middle-aged and 1.23 (0.95-1.59) for elderly.  
Conclusion: Multivariate HR is increased significantly only for middle-aged obese men and 
elderly underweight men.  In women, being underweight or obese carries a high mortality 
risk, irrespective of age.  The mortality risk due to being underweight or obese appears to be 
dependent upon sex and age group.  
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2. INTRODUCTION 
 
Review of previous studies 
Previously, several epidemiological studies have investigated the association between obesity 
and all-cause mortality based on body mass index (BMI) and suggested that this association 
changes with aging 
1-18
.  Almost all the results of these studies have suggested that the 
excess risk of mortality due to obesity attenuates with age 
1-16
.  The optimal BMI for 
longevity may shift toward obesity with aging.  However, there has long been a controversy 
regarding the effect of age on the association between underweight and all-cause mortality 
2-15, 17
.  Some studies have shown that the all-cause mortality decreases with aging 
5-13, 17
, 
whereas others have indicated that the excess risk of mortality increases with age 
3, 4
 or 
remains high irrespective of age 
2, 8, 13, 15
.  This inconsistency may be partly attributable to 
inability to control for subclinical disease or prior history of disease 
2, 7-10
, or inadequate 
adjustment for several other confounders
 6, 8-11, 15, 17
.  Additionally, there is possibility that 
data pertaining to this issue could have been affected by the relatively small proportion of 
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underweight participants in Western populations.  Several studies have failed to categorize 
the lowest BMI category of <18.5 because of the small proportion of such underweight 
individuals 
4, 6, 11, 13-15, 17
.  Thus the effect of age on the association between underweight and 
all-cause mortality remains to be clarified. 
 
Objective 
The issue addressed in the present study was whether the excess risk of mortality due to 
obesity also attenuates with age in the Japanese population, and that due to being 
underweight increases or decreases with aging, or remains high irrespective of age.  Japan 
has a high proportion of underweight individuals in comparison with Western populations.  
In the Global Database on Body Mass Index, the World Health Organization (WHO) has 
categorized 10-20% of Japanese as being underweight, compared with only 0-5% for Western 
populations 
19
.  Therefore the Japanese population would appear to be one of the best for 
clarifying the association between underweight and mortality.  I examined the effect of age 
on the association between BMI and all-cause mortality in a Japanese population, in an 
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attempt to address problems that had been encountered in previous studies.   
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3. METHODS 
Study subjects 
The present data were derived from the Ohsaki National Health Insurance (NHI) Cohort 
Study 
20-22
.  Briefly, I distributed a self-administered questionnaire on various lifestyle habits 
between October and December 1994 to all NHI beneficiaries aged 40 to 79 years who lived 
in the catchment area of Ohsaki Public Health Center, Miyagi Prefecture, northeastern Japan.  
Ohsaki Public Health Center is a local government agency that provides preventive health 
services to the residents of 14 municipalities in Miyagi Prefecture.  Out of 54,996 eligible 
individuals, 52,029 (95%) responded.  
For the present study, I excluded 776 participants who had withdrawn from the NHI 
before January 1, 1995, when I started prospective collection of NHI withdrawal history files.  
The remaining 51,253 participants formed the study cohort.   
Also, I excluded 1,767 participants who reported a history of cancer, 1,384 who reported 
a history of myocardial infarction, and 997 who reported a history of stroke, since the 
presence of these diseases at the baseline could have affected their BMI.  In addition, I 
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excluded 3,133 participants who did not provide information about body weight and height.  
As a result, a final total of 43,972 individuals (21,038 men and 22,934 women) participated.   
 
Exposure 
The self-administered questionnaire included questions on weight and height, and BMI was 
calculated as weight divided by the square of height (kg/m²).  I divided the participants into 
groups according to the following BMI categories: BMI<18.5 (underweight), 18.5-20.9, 
21.0-22.9, 23.0-24.9, 25.0-27.4, 27.5-29.9, and ≥30.0 kg/m² (obese).  These BMI categories 
correspond to the cut-off points proposed by the World Health Organization (WHO): normal 
BMI range (18.5-24.9 kg/m²), grade 1 overweight (25.0-29.9 kg/m²), grade 2 overweight 
(30.0-39.9 kg/m²), and grade 3 overweight (≥40.0 kg/m²) 23. 
The validity of self-reported body weight and height has been reported earlier 
20
.  Briefly, 
the weight and height of 14,883 participants, who were a subsample of the cohort, were 
measured during basic health examinations provided by local governments in 1995.  The 
Pearson's correlation coefficient (r) and weighted kappa (κ) between the self-reported values 
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and measured values were r=0.96 (p<0.01) for weight, r=0.93 (p<0.01) for height, and r=0.88 
(p<0.01) and κ=0.72 for BMI.  Thus, the self-reported weights and heights were considered 
to be sufficiently valid. 
 
Follow-up 
I followed up the participants from January 1, 1995 through March 31, 2008 and recorded 
any mortality or migration by reviewing the NHI withdrawal history files.  If a participant 
withdrew from the NHI system because of death, emigration, or employment, the withdrawal 
date and the reason for withdrawal were coded in the NHI withdrawal history files.  Because 
I was unable to obtain subsequent information on participants who withdrew from the NHI 
because of emigration or employment, I discontinued follow-up of such participants. 
The end point was all-cause mortality.  Data on the death of participants was based on 
the death certificates filed at Ohsaki Public Health Center.  Cases of death were coded by 
trained physicians according to the International Classification of Disease and Related Health 
Problems, the Tenth Revision (ICD-10) 
24
.  I identified deaths from cancer (codes C00-C97 
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and D00-09), cardiovascular disease (CVD, codes I00-I99), ischemic heart disease (IHD, 
codes I20-I25), stroke (I60-69), and pneumonia (codes J10-18).  Other deaths were defined 
all deaths without cancer, CVD, IHD, stroke, and pneumonia deaths. 
The person-years of follow-up were counted for each participant, until the date of death, 
withdrawal from the NHI, or the end of the study period, whichever occurred first.  After 
13.2 years of follow-up, the total number of person-years accrued was 478,729 and there 
were 6,694 deaths (4,278 men and 2,416 women). 
 
Ethics 
The study protocol was approved by the Ethics Committee of Tohoku University School of 
Medicine.  Participants who had returned the self-administered questionnaires and signed 
them were considered to have consented to participate. 
 
Statistical analysis 
I used Cox proportional-hazards regression analysis to calculate the hazard ratios (HRs) and 
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95% confidence intervals (CIs) for all-cause mortality according to BMI category and to 
adjust for potentially confounding factors, using the SAS version 9.2 statistical software 
package.  Stratified analyses were conducted based on two age-groups: middle-aged 
participants (aged 40-64 years) and elderly participants (aged 65-79 years).  All p values 
were two-tailed and differences at p<0.05 were accepted as statistically significant. 
I considered the following variables to be potential confounding factors: age (continuous 
variable), weight change since 20 years of age (loss of 10.0 kg or more, loss of 5.0-9.9 kg, 
change of less than ±5.0 kg, gain of 5.0-9.9 kg, or gain of 10.0 kg or more), education (junior 
high school or less, high school, or college/university or higher), marital status (married or 
unmarried), cigarette smoking (never smoker, past smoker, current smoker consuming 1-19 
cigarettes per day, or current smoker consuming at least 20 cigarettes per day), alcohol 
drinking (never drinker, past drinker, or current drinker), time spent walking per day (less 
than 1 hour, or 1 hour or longer), sports and physical exercise time per week (less than 1 hour, 
1-2 hours, 3-4 hours, or 5 hours or longer), history of kidney disease (presence or absence), 
and history of liver disease (presence or absence).  I did not adjust for hypertension and 
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diabetes mellitus in the multivariate models because these variables are considered to occupy 
an intermediate position in the etiologic pathway between BMI and all-cause mortality.  
Before including the above potential confounders into the multivariate models, I examined 
interactions between all-cause mortality and all potential confounders through the addition of 
cross-product terms to the multivariate model.  Based on the results of these analyses (data 
not shown), I included all the above variables into the multivariate models (Multivariate 
HRs1).   
In addition, I repeated the analyses after excluding the 739 participants who died within 
the first 2 years after the baseline (Multivariate HRs2).  
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4. RESULTS 
 
Baseline characteristics by BMI category 
The baseline characteristics of the study participants according to the 7 BMI categories are 
shown for men and women in Tables 1 and 2, respectively.  Among men and women, 3.5% 
and 4.1% were underweight, about half of each sex were in the BMI range 21.0-24.9 kg/m², 
23.5% and 28.3% were in the BMI range 25.0-29.9 kg/m², and 2.0% and 3.6% were obese, 
respectively. 
In men, mean age decreased linearly with increasing BMI category. In women, those who 
were underweight showed the oldest mean age.  The proportions of men and women who 
had lost ≥5 kg since 20 years of age decreased with increasing BMI category.  Educational 
background increased linearly in men and decreased in women as the BMI category increased.  
The proportions of men and women who were unmarried were high among those who were 
underweight or obese.  The proportions of men and women who were current smokers 
decreased with increasing BMI, and this tendency was especially marked in men.  The 
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proportions of men and women who had never drunk alcohol were highest in the underweight 
category.  Men and women who were underweight or had a BMI of ≥25 kg/m² were less 
likely to walk 1 hour or longer per day.  The proportions of individuals who did <1 hours 
sports and physical exercise per week were high among underweight women and among 
obese men and women.     
 
All-cause mortality by BMI category 
Table 3 (for men) and Table 4 (for women) show total person-years, the numbers of all-cause 
deaths, and HRs of all-cause mortality with 95% CIs according to the BMI and age-group 
categories.   
In men, I observed significantly increased risks for being underweight and obese among 
the participants as a whole.  Multivariate HRs1 (95%CI) were 1.44 (1.26-1.66) for the 
underweight and 1.36 (1.06-1.73) for the obese categories.  After stratification by age group, 
I observed a significantly increased excess risk of underweight mortality in the elderly.  
Multivariate HRs1 were 1.21 (0.90-1.63) in the middle-aged and 1.53 (1.31-1.79) in the 
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elderly.  I also observed a significantly increased excess risk of obese mortality in the 
middle-aged.  Multivariate HRs1 were 1.65 (1.17-2.34) in the middle-aged and 1.13 
(0.80-1.59) in the elderly.   
In women, I observed significantly increased risks for being underweight and obese 
among the participants as a whole.  Multivariate HRs1 were 1.37 (1.15-1.64) for the 
underweight and 1.25 (1.00-1.56) for the obese categories.  After stratification by age-group, 
I observed almost the same excess risk of mortality, irrespective of age group, as that for the 
participants as a whole in the underweight and obese categories, and a significantly increased 
excess risk of underweight mortality in the elderly.  Multivariate HRs1 were 1.32 
(0.89-1.97) in the middle-aged underweight, 1.34 (1.10-1.64) in the elderly underweight, 1.22 
(0.79-1.86) in the middle-aged obese, and 1.23 (0.95-1.59) in the elderly obese categories.  
After exclusion of participants who died during the first 2 years of follow-up, multivariate 
HRs2 showed similar association with multivariate HRs1 in men and women.  Exclusion of 
the 2-year follow-up slightly strengthened the positive association with a lower BMI, while 
the excess risk of mortality associated with a higher BMI was attenuated.   In women, I did 
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not observe any significantly increased risks for being obese among the participants as a 
whole.  Multivariate HR2 was 1.16 (0.92-1.47) among the participants as a whole.  
 
Cause-specific mortality by BMI category 
Table 3 (for men) and Table 4 (for women) also show the numbers of cause-specific deaths, 
and HRs of cause-specific mortality with 95% CIs according to the BMI and age-group 
categories.   
Among middle-aged obese men, cancer, CVD, stroke, and pneumonia mortalities showed 
equivalent to, or higher than all-cause mortality.  Multivariate HRs1 (95%CI) were 1.67 
(0.96-2.92) for cancer, 2.13 (1.06-4.26) for CVD, 2.03 (0.68-6.03) for stroke, and 2.34 
(0.47-11.79) for pneumonia.  In elderly underweight men, CVD, IHD, pneumonia, and 
others mortalities showed equivalent to, or higher than all-cause mortality.  Multivariate 
HRs1 (95%CI) were 1.52 (1.13-2.06) for CVD, 2.70 (1.50-4.84) for IHD, 2.82 (1.87-4.25) for 
pneumonia, and 1.51 (1.13-2.01) for other conditions. 
In underweight women, CVD, pneumonia, and other mortalities in the middle-aged, and 
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IHD, pneumonia, and other mortalities in the elderly showed equivalent to, or higher than 
all-cause mortality.  In the middle-aged, multivariate HRs1 (95%CI) were 1.61 (0.83-3.09) 
for CVD, 2.81 (0.19-40.91) for pneumonia, and 1.57 (0.76-3.24) for other.  In the elderly, 
multivariate HRs1 (95%CI) were 2.16 (1.06-4.41) for IHD, 2.49 (1.33-4.68) for pneumonia, 
and 1.64 (1.16-2.32) for other.  In obese women, cancer and other mortalities in the 
middle-aged, and CVD, IHD, and stroke mortalities in the elderly showed equivalent to, or 
higher than all-cause mortality.  In the middle-aged, multivariate HRs1 (95%CI) were 1.36 
(0.73-2.56) for cancer and 1.74 (0.76-3.97) for others. In the elderly, multivariate HRs1 
(95%CI) were 1.44 (0.96-2.15) for CVD, 1.81 (0.69-4.77) for IHD, 1.21 (0.67-2.21) for 
stroke. 
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5. DISCUSSION 
The present results indicate that the all-cause and cause-specific mortality risk due to being 
underweight or obese was dependent upon sex and age group.  All-cause mortality was 
higher in middle-aged obese men and elderly underweight men.  In women, the excess risk 
of mortality remained high irrespective of age-group for the underweight and obesity.   
   In men, all-cause mortality was significantly higher for the obese middle-aged and the 
underweight elderly.  In women, I observed a significant elevation of all-cause mortality 
only in the underweight elderly after stratification by age group.  However, point estimates 
of all-cause mortality in the underweight and obese middle-aged were increased to a similar 
extent as those for the underweight and obese elderly, respectively.  Before stratification by 
age group, all-cause mortality was significantly increased in all underweight and obese 
women, and also showed point estimates similar to those for the middle-aged and elderly 
underweight and obesity, respectively.  The significantly increased all-cause mortality in 
only elderly women after stratification by age group may have been attributable to decrease 
statistical power resulting from a decrease in number of participants.  Thus, although 
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all-cause mortality was not significantly increased, I consider that being underweight and 
obesity probably increased all-cause mortality in women, irrespective of age. 
    
Comparison with previous studies 
Almost all
 
previous studies have agreed that excess risk of mortality due to obesity decreases 
with age 
1-16
,
 
and the present result reflects this in men.  However, the excess risk of 
mortality remained high, irrespective of age group, for obese women.  For underweight 
participants, the results of previous studies have been inconsistent 
2-15, 17
.  The present 
results are in agreement with 2 of 14 studies for men 
3, 4
,
 
and 4 of 13 studies for women 
2, 8, 13, 
15
.  Other studies have shown that the excess risk of mortality attenuated with age in men 
and/or women 
5-13, 17
, remained high irrespective of age in men 
2
,
 
or increased with age in 
women 
3, 4
.  
In Japan, Matsuo et al. have reported the effect of age on the association between BMI 
and all-cause mortality 
8
.  Their findings agreed with the present ones, except for the data 
for underweight men and obese women.  In their multivariate analysis, they adjusted only 
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for age, alcohol intake, and smoking status, and their study population included participants 
who had a history of disease.  Furthermore, their age groups were defined as 40-59 years 
(middle-aged) and 60-79 years (elderly).  These factors accounted for the partial 
inconsistency between the present results and those of this previous Japanese study.    
 
Contributions of cause-specific mortality to increased all-cause morality 
In underweight participants, the excess risk of mortality increased with aging in men and 
remained high, irrespective of age group, in women.  The underweight participants had a 
high mortality risk because of increased pneumonia mortality, irrespective of age group.  
Inoue et al. also showed that in a Japanese population a low BMI was associated with higher 
pneumonia mortality, whereas the reverse was true for a high BMI 
25
.  Underweight 
individuals have several risk factors for pneumonia mortality, such as malnutrition 
26
, chronic 
obstructive pulmonary disease 
26, 27
, and dysphagia 
28, 29
.  Thus an increase of pneumonia 
mortality in underweight individuals is plausible.  In the elderly, mortality due to not only 
pneumonia but also CVD, particularly IHD, was increased in those who were underweight.  
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Flegal et al. showed that the excess risk of CVD mortality increased with aging in the 
underweight 
30
.  Underweight individuals are known to have a risk of compromised 
immunity 
20, 31, 32
 and an increased risk of chronic infection, which can cause IHD 
20, 33-37
.     
CVD mortality also contributes to increased mortality in middle-aged underweight women.  
This inconsistency between men and women may be partly attributable to high estrogen 
levels in premenopausal women.  Although a previous study has shown that estrogen 
prevents heart disease 
38
, individuals with a low BMI secrete a lower level of estrogen than 
those with a high BMI 
39
. 
In obese participants of the present study, the excess risk of mortality decreased with 
aging in men and remained high, irrespective of age group, in women.  The World Cancer 
Research Fund and the American Institute for Cancer Research have concluded that obesity 
contributes to an increased risk of cancers of the oesophagus, colorectum, endometrium, 
kidney, pancreas and breast among postmenopausal women, 
40
.  The apparent decrease of 
cancer mortality in obese individuals with aging might be attributable to survival bias.  A 
previous study has demonstrated a null association between BMI and excess risk of cancer 
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mortality in individuals aged ≥70 years 30.  Also, pneumonia mortality decreases with aging 
in men.  It has been demonstrated previously that there is a U-shaped association between 
BMI and immune dysfunction 
41
.  However, several studies have produced inconsistent 
results regarding the association between mortality due to obesity and pneumonia or 
respiratory disease in Asia 
25, 42-44
.  In the present study, I observed only two events due to 
pneumonia death in middle-aged men.  The association between middle-aged obesity and an 
excess risk of pneumonia mortality may have been attributable to chance.  Although CVD 
mortality increased irrespective of age, because obesity contributes to CVD risk factors such 
as hypertension 
45-47
, dyslipidemia
48, 49
, and diabetes 
50-53
, all cause mortality in men 
decreases with aging due to a decrease of both cancer and pneumonia mortality.  Obese 
women showed a high CVD mortality, but only in the elderly.  In general, men tend to have 
central obesity, with accumulation of adipose tissue in the abdominal region, whereas women 
tend to have subcutaneous obesity, with accumulation of adipose tissue in the gluteal-femoral 
region 
54
.  Accumulation of visceral fat is associated with insulin resistance 
55, 56
, increased 
levels of free fatty acids 
57
, and increased CVD mortality 
58-60
.  However, even women with 
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subcutaneous obesity can accumulate visceral fat in the post-menopausal period with aging 
54, 
61
.  Therefore, among women, only the elderly and obese showed an excess risk of CVD 
mortality.  Accordingly, the present results for women were inconsistent with previous 
studies.  The high mortality irrespective of age was attributable to an age-related decrease of 
mortality due to cancer but an increase of mortality due to CVD. 
 
Reverse causation and bias 
The existence of subclinical disease partly explained the excess risk of mortality associated 
with being underweight.  Weight loss can be attributable to the presence of subclinical 
disease.  To address the reverse causation attributable to subclinical disease, I excluded 
from analysis the 739 participants who died within the first 2 years after the baseline.  This 
exclusion slightly strengthened the excess risk of mortality in underweight individuals, 
whereas the positive association with obesity was slightly attenuated.  Multivariate HRs2 
showed a similar association with HRs1 in men and women.  Thus, reverse causation due 
to subclinical disease may not have affected the present results.  
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As I used self-reported BMI obtained at the baseline, no data on changes in BMI during 
follow-up were available.  Niedhammer et al. have shown that there is a systematic bias in 
self-reported weight and height 
29
.  However, I consider these biases to be a nondifferential 
misclassification that is not dependent upon all-cause death.  This misclassification 
weakens the true association towards the null.  van Dam et al. studied the association 
between BMI and mortality using lower BMI cutoff points: 24.5 kg/m
2
 to reflect a measured 
BMI of 25.0 kg/m
2
, and 29.0 kg/m
2
 to reflect a measured BMI of 30.0 kg/m
2
.  The 
association was similar to that for the original cut-off points. 
Previous studies have shown that self-reported BMI is correlated with measured BMI, and 
that the mean difference is relatively small.  I have also evaluated the validity of 
self-reported BMI, and demonstrated that it has a high correlation with measured BMI in a 
subsample of 14,883 participants (r=0.88, p<0.01).  Therefore, self-reported BMI is 
considered to be sufficiently useful. 
I also considered several important confounding factors.  Cigarette smoking, alcohol 
consumption, and physical activity are major confounding factors associated with both BMI 
26 
 
and mortality 
1-17
.  I also considered education level and marital status as potential 
confounding factors, similarly to previous studies 
1, 2, 6, 7, 10, 12-14
.  Furthermore, the presence 
of subclinical disease and a history of disease could be associated with weight loss and 
increase the risk of death 
1, 2, 5, 6, 8, 11-17
.  To remove any effect of medical history, I excluded 
participants who had histories of cancer, myocardial infarction, and stroke and also adjusted 
for weight change since 20 years of age, history of kidney disease, and history of liver disease 
in multivariate analysis.   
 
Implications 
In Japan, health check-ups for metabolic syndrome have been conducted since 2008. 
Meanwhile, the risk of being underweight has long been ignored.  Compared with obesity, 
preventive measures against becoming underweight have been delayed.  However, the 
present study showed that being underweight represents a high mortality risk in elderly men 
and women, irrespective of age group.  Grabowski et al. and Sergi et al. have shown that a 
low BMI in elderly individuals is a predictor of mortality 
62, 63
. 
 
Okoro et al. showed that 
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being underweight and elderly was associated with subsequent disability 
64
.  In Asian 
populations, the excess risk of mortality is higher among underweight than among obese 
individuals 
42
.  Therefore, it appears necessary to develop a system for medical and 
nutritional assessment, and intervention for underweight individuals, especially the elderly. 
The present study showed that the contribution of cause-specific mortality to excess risk 
of all-cause mortality differed according to sex and age.  Previously, only Flegal et al. 
investigated not only the association between BMI and all-cause mortality, but also the 
contributions of cause-specific mortality to increase all-cause mortality according to 
middle-aged and elderly 
30
.  Therefore, the effect of age on the association between BMI, 
all-cause mortality, and cause-specific mortality remains to be clarified.  I partly supported 
the previous study.  Although I observed the high point estimate of cause-specific mortality, 
I only observed statistical significant association in pneumonia and CVD mortality because of 
lack of statistical power.  Additional large research studies are needed to clarify the 
contributions of cause-specific mortality to increased all-cause mortality according to 
middle-aged and elderly.  
28 
 
Strengths 
A major strength of the present study was that the participants were recruited from the 
general Japanese population.  According to the WHO Global Database on Body Mass Index, 
Japan has a higher prevalence of underweight individuals (10-20%) than Western populations 
(0-5%).  Therefore, the Japanese population would be one of the most appropriate 
populations in which to examine the excess risk of mortality posed by being underweight.   
 
Limitations 
On the other hand, several limitations of the present study should be considered.  First, as a 
result of stratification by age-group, there was a possibility of beta error because of 
inadequate numbers of participants and events.  Second, although BMI has been accepted as 
an index of underweight and obesity, it might be an insufficient index for assessment of 
adiposity.  It cannot distinguish distributions of adiposity and lean body mass.  Additionally, 
it is a less valid index of adiposity in elderly than in middle-age individuals 
65-67
.  The high 
excess risk of mortality in underweight individuals can be partly explained by abdominal fat.  
29 
 
All-cause mortality increases in parallel with waist-to-hip ratio or waist circumference in 
underweight individuals 
12, 68
. 
 
Conclusion 
In summary, obesity carries a high mortality risk in middle-aged men, whereas being 
underweight, rather than obese, carries a high mortality risk in elderly men.  In women, 
underweight and obesity retain a high mortality risk irrespective of age.  Thus, the mortality 
risk associated with being underweight or obese is dependent upon sex and age-group. 
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8. TABLES
Table 1. Baseline characteristics by BMI
a
 categories in 21,038 men aged 40-79 years.
<18.5 18.5-20.9 21.0-22.9 23.0-24.9 25.0-27.4 27.5-29.9 ≥30.0 p valueb
No. of subjects 732 3,677 5,617 5,657 3,726 1,213 416
Mean age (years) (SD
a
) 64.2 (10.4) 60.2 (10.9) 59.3 (10.6) 58.5 (10.3) 57.7 (10.2)  56.6 (10.1) 56.4 (10.4) <0.0001
Mean weight (kg) (SD) 47.8 (4.9) 53.5 (4.7) 58.4 (4.9) 63.6 (5.3) 69.2 (5.9) 76.1 (6.8) 85.4 (16.9) <0.0001
Mean height (cm) (SD) 165.2 (7.9) 163.3 (6.8) 162.6 (6.7) 162.9 (6.5) 162.9 (6.7) 163.5 (7.1) 161.2 (11.2) <0.0001
Mean BMI (kg/m²) (SD) 17.5 (1.0) 20.0 (0.7) 22.0 (0.5) 23.9 (0.6) 26.1 (0.7) 28.4 (0.7) 32.9 (5.8) <0.0001
Weight change since 20 years old (%)
  ≤-10.0 kg 41.9 17.4 7.4 4.1 1.9 2.7 1.5 <0.0001
  -9.9～-5.0 kg 28.0 28.2 20.1 10.8 5.7 4.0 3.5
　-4.9～+4.9 kg 27.4 48.2 52.3 38.3 18.6 8.4 6.2
  +5.0～+9.9 kg 2.3 5.1 16.3 29.5 28.4 14.1 7.4
  ≥+10.0 kg 0.4 1.1 3.9 17.4 45.5 70.9 81.5
Education (%)
  Junior high school or less 64.2 63.6 62.8 60.5 58.3 58.9 59.3 <0.0001
  High school 27.2 29.2 30.3 31.5 33.8 33.5 32.8
  College/university or higher 8.6 7.2 7.0 8.0 7.9 7.6 7.9
Marital status (%)
  Married 87.4 88.4 89.2 89.6 89.5 90.6 84.2 0.0072
  Unmarried 12.6 11.7 10.8 10.5 10.5 9.4 15.8
Smoking status (%)
  Never smoker 12.9 13.5 16.9 20.5 23.1 24.5 24.9 <0.0001
  Past smoker 26.0 21.2 23.5 25.4 28.7 26.4 23.4
  Current smoker, 1-19 cigarettes/day 29.9 28.3 23.8 20.7 16.5 13.9 14.9
　Current smoker, ≥20 cigarettes/day 31.2 37.1 35.7 33.3 31.7 35.2 36.8
Alcohol drinking (%)
  Never drinker 21.1 16.6 16.3 16.0 15.8 16.4 20.0 <0.0001
  Past drinker 19.9 11.7 10.0 8.4 9.3 7.4 11.3
  Current drinker 59.0 71.7 73.7 75.6 74.9 76.2 68.7
Time spent walking (%)
　≥1 hour/day 40.1 52.3 51.1 49.9 45.8 45.0 42.8 <0.0001
　<1 hour/day 59.9 47.7 48.9 50.1 54.2 55.0 57.2
Sports and physical exercise (%)
　≥5 hours/week 10.1 9.6 9.4 9.3 7.5 7.0 7.0 0.0026
  3-4 hours/week 6.8 6.3 6.6 6.8 6.8 5.8 3.9
  1-2 hours/week 13.5 14.0 15.8 15.2 16.0 17.8 15.8
  <1 hour/week 69.7 70.0 68.2 68.8 69.7 69.4 73.4
History of kidney disease (%)
  Presence 4.8 4.1 3.3 3.5 3.5 4.2 2.9 NS
a
  Absence 95.2 95.9 96.7 96.5 96.5 95.8 97.1
History of liver disease (%)
  Presence 7.4 6.9 6.1 6.6 7.1 7.6 8.9 NS
  Absence 92.6 93.1 93.9 93.4 92.9 92.4 91.1
b
p  values were calculated by chi-squared test (categorical variables), or ANOVA (continuous variables).
BMI (kg/m²)
a
BMI, body mass index; SD, standard deviation; NS, not significant.
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Table 2. Baseline characteristics by BMI
a
 categories in 22,934 women aged 40-79 years.
<18.5 18.5-20.9 21.0-22.9 23.0-24.9 25.0-27.4 27.5-29.9 ≥30.0 p valueb
No. of subjects 928 3,518 5,498 5,676 4,556 1,929 829
Mean age (years) (SD
a
) 63.8 (10.8) 60.3 (10.8) 59.8 (10.2) 59.7 (9.7) 60.9 (9.2) 60.7 (9.2) 61.1 (9.5) <0.0001
Mean weight (kg) (SD) 40.7 (4.5) 46.2 (4.0) 50.5 (3.9) 55.1 (4.2) 59.6 (4.6) 64.5 (5.2) 71.2 (11.6) <0.0001
Mean height (cm) (SD) 153.2 (8.4) 152.0 (5.9) 151.3 (5.5) 151.5 (5.5) 150.9 (5.6) 150.2 (5.9) 147.5 (9.7) <0.0001
Mean BMI (kg/m²) (SD) 17.3 (1.1) 20.0 (0.7) 22.0 (0.6) 24.0 (0.6) 26.1 (0.7) 28.5 (0.7) 32.8 (5.0) <0.0001
Weight change since 20 years old (%)
  ≤-10.0 kg 31.2 13.7 6.2 2.2 1.4 1.1 1.0 <0.0001
  -9.9～-5.0 kg 32.4 27.3 17.9 9.0 4.7 2.4 2.0
　-4.9～+4.9 kg 34.1 50.3 50.5 36.7 17.3 10.0 5.1
  +5.0～+9.9 kg 2.0 7.7 20.3 33.6 32.4 19.3 8.9
  ≥+10.0 kg 0.4 0.9 5.0 18.6 44.2 67.2 83.1
Education (%)
  Junior high school or less 58.0 52.7 53.7 55.0 61.4 64.6 71.2 <0.0001
  High school 34.0 38.0 36.9 36.6 32.2 28.9 24.5
  College/university or higher 7.9 9.4 9.5 8.4 6.4 6.6 4.3
Marital status (%)
  Married 66.5 74.1 76.4 77.5 76.9 77.4 73.2 <0.0001
  Unmarried 33.5 26.0 23.6 22.5 23.1 22.7 26.8
Smoking status (%)
  Never smoker 81.9 85.5 89.2 90.4 90.2 89.2 88.7 <0.0001
  Past smoker 3.2 2.5 2.2 2.5 2.5 2.6 3.3
  Current smoker, 1-19 cigarettes/day 11.4 8.4 6.3 5.2 5.4 5.4 4.7
　Current smoker, ≥20 cigarettes/day 3.5 3.6 2.3 1.9 1.9 2.9 3.4
Alcohol drinking (%)
  Never drinker 74.8 70.9 72.9 72.2 72.9 72.4 71.2 0.0002
  Past drinker 5.4 4.8 3.9 3.9 4.1 5.3 7.4
  Current drinker 19.8 24.3 23.3 23.9 23.0 22.3 21.4
Time spent walking (%)
　≥1 hour/day 37.5 44.8 44.4 44.9 41.8 38.0 35.0 <0.0001
　<1 hour/day 62.5 55.3 55.7 55.1 58.2 62.0 65.0
Sports and physical exercise (%)
　≥5 hours/week 4.1 5.3 5.2 5.4 5.5 4.4 6.0 0.0249
  3-4 hours/week 5.4 5.6 6.1 6.1 6.1 5.7 4.6
  1-2 hours/week 13.3 14.7 15.9 16.2 17.0 15.9 12.2
  <1 hour/week 77.2 74.4 72.8 72.4 71.4 74.0 77.1
History of kidney disease (%)
  Presence 5.3 4.9 4.1 3.5 3.6 4.1 3.7 0.0057
  Absence 94.7 95.1 95.9 96.5 96.4 95.9 96.3
History of liver disease (%)
  Presence 4.5 3.8 4.3 4.3 3.8 4.5 5.9 NS
a
  Absence 95.5 96.2 95.7 95.7 96.2 95.5 94.1
b
p  values were calculated by chi-squared test (categorical variables), or ANOVA (continuous variables).
BMI (kg/m²)
a
BMI, body mass index; SD, standard deviation; NS, not significant.
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<18.5 18.5-20.9 21.0-22.9 23.0-24.9 25.0-27.4 27.5-29.9 ≥30.0
Total
    No. of subjects 732 3,677 5,617 5,657 3,726 1,213 416
    Person-years 6,738 38,218 60,407 62,133 41,264 13,589 4,527
        All-cause
             No. of deaths 302 924 1,155 1,008 612 201 76
             Crude 2.84 (2.50-3.23) 1.50 (1.38-1.64) 1.18 (1.09-1.29) 1.00 (reference) 0.91 (0.83-1.01) 0.91 (0.78-1.06) 1.04 (0.82-1.31)
             Age-adjusted HRs 1.92 (1.68-2.18) 1.30 (1.19-1.42) 1.10 (1.01-1.20) 1.00 (reference) 0.97 (0.88-1.07) 1.05 (0.91-1.23) 1.25 (0.99-1.57)
             Multivariate HRs1
b 1.44 (1.26-1.66) 1.10 (1.00-1.21) 1.03 (0.95-1.13) 1.00 (reference) 1.03 (0.93-1.14) 1.13 (0.96-1.32) 1.36 (1.06-1.73)
             Multivariate HRs2
c 1.45 (1.25-1.69) 1.11 (1.00-1.23) 1.02 (0.93-1.12) 1.00 (reference) 0.99 (0.89-1.11) 1.04 (0.88-1.23) 1.30 (1.00-1.68)
        Cancer
             No. of deaths 81 327 427 374 238 76 27
             Multivariate HRs1 1.16 (0.90-1.50) 1.10 (0.94-1.29) 1.05 (0.91-1.20) 1.00 (reference) 1.07 (0.90-1.26) 1.14 (0.88-1.48) 1.32 (0.88-1.98)
        CVD
             No. of deaths 77 231 278 258 162 59 26
             Multivariate HRs1 1.35 (1.03-1.77) 1.05 (0.87-1.26) 0.95 (0.80-1.13) 1.00 (reference) 1.09 (0.89-1.34) 1.34 (1.00-1.81) 1.98 (1.29-3.03)
          IHD
               No. of deaths 24 58 76 60 28 17 4
              Multivariate HRs1 1.99 (1.19-3.32) 1.16 (0.79-1.71) 1.15 (0.81-1.62) 1.00 (reference) 0.87 (0.55-1.37) 1.93 (1.09-3.41) 1.67 (0.58-4.82)
          Stroke
               No. of deaths 26 107 117 109 79 23 11
              Multivariate HRs1 1.20 (0.76-1.89) 1.27 (0.95-1.68) 1.01 (0.77-1.31) 1.00 (reference) 1.20 (0.89-1.63) 1.18 (0.74-1.88) 1.86 (0.96-3.58)
        Pneumonia
             No. of deaths 50 115 110 74 50 16 6
             Multivariate HRs1 2.76 (1.88-4.07) 1.66 (1.22-2.26) 1.24 (0.92-1.68) 1.00 (reference) 1.14 (0.79-1.66) 1.17 (0.67-2.06) 1.39 (0.58-3.35)
        Other
             No. of deaths 94 251 340 302 162 50 17
             Multivariate HRs1 1.48 (1.16-1.90) 1.01 (0.84-1.20) 1.03 (0.88-1.21) 1.00 (reference) 0.90 (0.74-1.10) 0.92 (0.67-1.25) 0.93 (0.56-1.55)
(continued)
Table 3.　HRa and 95% CIa of all-cause and cause-specific mortality by  BMIa  categories stratified by age-group in men.
BMI
45
40-64 y
    No. of subjects 310 2,159 3,591 3,852 2,637 903 312
    Person-years 3,318 23,946 40,235 43,751 29,929 10,290 3,513
        All-cause
             No. of deaths 53 262 396 372 249 91 39
             Multivariate HRs1 1.21 (0.90-1.63) 1.04 (0.88-1.23) 1.07 (0.93-1.24) 1.00 (reference) 1.11 (0.94-1.31) 1.25 (0.98-1.60) 1.65 (1.17-2.34)
        Cancer
             No. of deaths 25 107 152 157 105 44 15
             Multivariate HRs1 1.38 (0.89-2.14) 1.02 (0.79-1.33) 0.99 (0.79-1.24) 1.00 (reference) 1.14 (0.88-1.47) 1.52 (1.06-2.17) 1.67 (0.96-2.92)
        CVD
             No. of deaths 7 67 87 85 64 23 10
             Multivariate HRs1 0.67 (0.31-1.48) 1.09 (0.78-1.53) 1.00 (0.74-1.36) 1.00 (reference) 1.33 (0.95-1.86) 1.51 (0.93-2.47) 2.13 (1.06-4.26)
          IHD
               No. of deaths 2 17 27 26 10 5 1
               Multivariate HRs1 0.66 (0.15-2.89) 0.92 (0.48-1.75) 1.01 (0.58-1.76) 1.00 (reference) 0.71 (0.34-1.50) 1.32 (0.47-3.71) 0.83 (0.11-6.54)
          Stroke
               No. of deaths 3 30 35 32 32 8 4
               Multivariate HRs1 0.96 (0.29-3.23) 1.51 (0.89-2.56) 1.16 (0.71-1.89) 1.00 (reference) 1.70 (1.02-2.82) 1.31 (0.58-2.96) 2.03 (0.68-6.03)
        Pneumonia
             No. of deaths 3 20 25 12 7 5 2
             Multivariate HRs1 1.60 (0.43-5.97) 2.26 (1.06-4.80) 1.96 (0.97-3.98) 1.00 (reference) 0.90 (0.34-2.38) 2.04 (0.66-6.31) 2.34 (0.47-11.79)
        Other
             No. of deaths 18 68 132 118 73 19 12
             Multivariate HRs1 1.33 (0.79-2.23) 0.88 (0.64-1.20) 1.14 (0.88-1.48) 1.00 (reference) 0.94 (0.70-1.28) 0.71 (0.43-1.19) 1.26 (0.68-2.36)
(continued)
Table 3.　Continued
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65-79 y
    No. of subjects 422 1,518 2,026 1,805 1,089 310 104
    Person-years 3,420 14,271 20,172 18,382 11,335 3,299 1,013
        All-cause
             No. of deaths 249 662 759 636 363 110 37
             Multivariate HRs1 1.53 (1.31-1.79) 1.14 (1.01-1.28) 1.02 (0.91-1.13) 1.00 (reference) 0.98 (0.86-1.12) 1.05 (0.85-1.29) 1.13 (0.80-1.59)
        Cancer
             No. of deaths 56 220 275 217 133 32 12
             Multivariate HRs1 1.17 (0.86-1.59) 1.18 (0.97-1.45) 1.12 (0.93-1.34) 1.00 (reference) 1.03 (0.82-1.29) 0.87 (0.59-1.28) 1.05 (0.58-1.93)
        CVD
             No. of deaths 70 164 191 173 98 36 16
             Multivariate HRs1 1.52 (1.13-2.06) 1.04 (0.83-1.31) 0.94 (0.77-1.17) 1.00 (reference) 0.97 (0.75-1.26) 1.24 (0.85-1.81) 1.66 (0.96-2.85)
          IHD
               No. of deaths 22 41 49 34 18 12 3
               Multivariate HRs1 2.70 (1.50-4.84) 1.39 (0.86-2.24) 1.28 (0.82-2.00) 1.00 (reference) 0.98 (0.54-1.76) 2.45 (1.22-4.91) 2.07 (0.60-7.13)
          Stroke
               No. of deaths 23 77 82 77 47 15 7
               Multivariate HRs1 1.19 (0.72-1.95) 1.18 (0.84-1.66) 0.96 (0.69-1.31) 1.00 (reference) 1.00 (0.68-1.45) 1.11 (0.62-1.99) 1.51 (0.66-3.43)
        Pneumonia
             No. of deaths 47 95 85 62 43 11 4
             Multivariate HRs1 2.82 (1.87-4.25) 1.58 (1.12-2.21) 1.13 (0.81-1.58) 1.00 (reference) 1.17 (0.78-1.76) 0.95 (0.49-1.85) 1.09 (0.38-3.14)
        Other
             No. of deaths 76 183 208 184 89 31 5
             Multivariate HRs1 1.51 (1.13-2.01) 1.05 (0.84-1.30) 0.96 (0.78-1.18) 1.00 (reference) 0.86 (0.66-1.12) 1.07 (0.72-1.59) 0.53 (0.21-1.31)
c
 Multivariate HRs2 was excluded from multivariate HRs1 the 473 men who died within the 2 years after baseline.
Table 3.　Continued
a
 HR, hazard ratio; CI, confidence interval; BMI, body mass index.
b 
Multivariate HRs1 was adjusted for age  (continuous variable); weight change since 20 years old (loss of 10.0 kg or more, loss of 5.0-9.9 kg, change of less than ±
5.0 kg, gain of 5.0-9.9 kg, or gain of 10.0 kg or more); education (junior high school or less, high school, or college/university or higher); marital status (married or
unmarried); cigarette smoking (never smoker, past smoker, current smoker consuming 1-19 cigarettes per day, or current smoker consuming at least 20 cigarettes
per day); alcohol drinking (never drinker, past drinker, or current drinker); time spent walking per day (less than 1 hour, or 1hour or longer); sports and physical
exercise time per week (less than 1 hour, 1-2 hours, 3-4 hours, or 5 hours or longer); history of kidney disease (presence or absence); history of liver disease
(presence or absence).
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<18.5 18.5-20.9 21.0-22.9 23.0-24.9 25.0-27.4 27.5-29.9 ≥30.0
Total
    No. of subjects 928 3,518 5,498 5,676 4,556 1,929 829
    Person-years 9,776 37,853 60,745 62,739 50,454 21,222 9,064
        All-cause
             No. of deaths 189 436 538 499 450 197 107
             Crude 2.45 (2.08-2.90) 1.45 (1.28-1.65) 1.11 (0.99-1.26) 1.00 (reference) 1.12 (0.99-1.27) 1.17 (0.99-1.38) 1.49 (1.21-1.83)
             Age-adjusted HRs 1.66 (1.40-1.96) 1.29 (1.13-1.46) 1.05 (0.93-1.19) 1.00 (reference) 1.06 (0.93-1.21) 1.11 (0.94-1.31) 1.35 (1.09-1.66)
             Multivariate HRs1
b 1.37 (1.15-1.64) 1.15 (1.00-1.31) 0.99 (0.87-1.12) 1.00 (reference) 1.07 (0.94-1.22) 1.08 (0.91-1.29) 1.25 (1.00-1.56)
             Multivariate HRs2
c 1.38 (1.14-1.67) 1.20 (1.04-1.39) 1.03 (0.90-1.17) 1.00 (reference) 1.08 (0.94-1.24) 1.08 (0.89-1.29) 1.16 (0.92-1.47)
        Cancer
             No. of deaths 34 103 148 164 139 64 34
             Multivariate HRs1 0.93 (0.63-1.38) 0.93 (0.71-1.21) 0.88 (0.70-1.11) 1.00 (reference) 0.99 (0.78-1.25) 1.04 (0.77-1.42) 1.21 (0.81-1.79)
        CVD
             No. of deaths 67 146 175 172 164 69 42
             Multivariate HRs1 1.27 (0.94-1.71) 1.06 (0.84-1.34) 0.92 (0.74-1.13) 1.00 (reference) 1.11 (0.89-1.39) 1.06 (0.79-1.43) 1.31 (0.92-1.88)
          IHD
               No. of deaths 19 25 34 32 38 19 7
              Multivariate HRs1 1.77 (0.97-3.24) 0.87 (0.50-1.50) 0.89 (0.55-1.46) 1.00 (reference) 1.53 (0.94-2.48) 1.87 (1.03-3.41) 1.42 (0.60-3.36)
          Stroke
               No. of deaths 28 73 78 94 73 34 20
              Multivariate HRs1 1.05 (0.67-1.63) 1.01 (0.73-1.40) 0.76 (0.56-1.03) 1.00 (reference) 0.90 (0.66-1.23) 0.96 (0.64-1.45) 1.18 (0.70-1.97)
        Pneumonia
             No. of deaths 21 37 42 25 37 8 5
             Multivariate HRs1 2.59 (1.40-4.78) 1.81 (1.06-3.07) 1.44 (0.87-2.38) 1.00 (reference) 1.72 (1.02-2.91) 0.78 (0.34-1.78) 0.97 (0.36-2.66)
        Other
             No. of deaths 67 150 173 138 110 56 26
             Multivariate HRs1 1.69 (1.24-2.31) 1.37 (1.07-1.75) 1.12 (0.89-1.41) 1.00 (reference) 1.00 (0.78-1.30) 1.24 (0.89-1.72) 1.30 (0.83-2.03)
(continued)
Table 4.　HRa and 95% CIa of all-cause and cause-specificmortality by  BMIa  categories stratified by age-group in women.
BMI
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40-64 y
    No. of subjects 425 2,135 3,521 3,770 2,890 1,227 489
    Person-years 4,816 23,228 39,068 41,817 32,161 13,632 5,468
        All-cause
             No. of deaths 34 109 154 153 134 58 28
             Multivariate HRs1 1.32 (0.89-1.97) 1.11 (0.85-1.45) 1.03 (0.82-1.30) 1.00 (reference) 1.07 (0.84-1.36) 1.05 (0.76-1.45) 1.22 (0.79-1.86)
        Cancer
             No. of deaths 8 36 63 69 66 24 13
             Multivariate HRs1 0.86 (0.40-1.85) 0.92 (0.59-1.42) 0.99 (0.69-1.41) 1.00 (reference) 1.17 (0.82-1.66) 1.01 (0.62-1.66) 1.36 (0.73-2.56)
        CVD
             No. of deaths 14 33 35 48 29 18 7
             Multivariate HRs1 1.61 (0.83-3.09) 1.04 (0.64-1.70) 0.75 (0.48-1.19) 1.00 (reference) 0.68 (0.42-1.10) 0.91 (0.51-1.62) 0.82 (0.35-1.88)
          IHD
               No. of deaths 4 3 9 13 5 5 1
               Multivariate HRs1 1.10 (0.32-3.79) 0.23 (0.06-0.84) 0.54 (0.22-1.32) 1.00 (reference) 0.50 (0.17-1.46) 1.21 (0.39-3.76) 0.59 (0.07-4.96)
          Stroke
               No. of deaths 5 16 18 29 14 9 5
               Multivariate HRs1 1.10 (0.40-3.06) 0.92 (0.47-1.80) 0.68 (0.37-1.25) 1.00 (reference) 0.55 (0.29-1.06) 0.79 (0.36-1.75) 1.06 (0.38-2.92)
        Pneumonia
             No. of deaths 1 3 5 2 6 0 0
             Multivariate HRs1 2.81 (0.19-40.91) 2.75 (0.38-19.87) 3.05 (0.56-16.77) 1.00 (reference) 3.03 (0.59-15.64) - -
        Other
             No. of deaths 11 37 51 34 33 16 8
             Multivariate HRs1 1.57 (0.76-3.24) 1.45 (0.88-2.39) 1.40 (0.90-2.19) 1.00 (reference) 1.32 (0.80-2.16) 1.47 (0.78-2.77) 1.74 (0.76-3.97)
(continued)
Table 4.　Continued
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65-79 y
    No. of subjects 503 1,383 1,977 1,906 1,666 702 340
    Person-years 4,960 14,625 21,677 20,922 18,293 7,589 3,596
        All-cause
             No. of deaths 155 327 384 346 316 139 79
             Multivariate HRs1 1.34 (1.10-1.64) 1.13 (0.97-1.33) 0.96 (0.83-1.12) 1.00 (reference) 1.08 (0.92-1.26) 1.08 (0.88-1.33) 1.23 (0.95-1.59)
        Cancer
             No. of deaths 26 67 85 95 73 40 21
             Multivariate HRs1 0.96 (0.61-1.51) 0.92 (0.66-1.28) 0.81 (0.60-1.09) 1.00 (reference) 0.86 (0.63-1.18) 1.06 (0.72-1.57) 1.09 (0.66-1.81)
        CVD
             No. of deaths 53 113 140 124 135 51 35
             Multivariate HRs1 1.20 (0.86-1.69) 1.06 (0.81-1.38) 0.97 (0.76-1.23) 1.00 (reference) 1.29 (1.00-1.66) 1.10 (0.78-1.54) 1.44 (0.96-2.15)
          IHD
               No. of deaths 15 22 25 19 33 14 6
               Multivariate HRs1 2.16 (1.06-4.41) 1.25 (0.66-2.36) 1.08 (0.59-1.98) 1.00 (reference) 2.22 (1.24-3.95) 2.27 (1.11-4.68) 1.81 (0.69-4.77)
          Stroke
               No. of deaths 23 57 60 65 59 25 15
               Multivariate HRs1 1.04 (0.63-1.72) 1.05 (0.72-1.52) 0.79 (0.56-1.14) 1.00 (reference) 1.07 (0.74-1.54) 1.02 (0.62-1.65) 1.21 (0.67-2.21)
        Pneumonia
             No. of deaths 20 34 37 23 31 8 5
             Multivariate HRs1 2.49 (1.33-4.68) 1.70 (0.98-2.95) 1.32 (0.78-2.25) 1.00 (reference) 1.63 (0.93-2.85) 0.87 (0.38-2.02) 1.05 (0.38-2.91)
        Other
             No. of deaths 56 113 122 104 77 40 18
             Multivariate HRs1 1.64 (1.16-2.32) 1.31 (0.99-1.73) 1.03 (0.79-1.34) 1.00 (reference) 0.91 (0.68-1.23) 1.15 (0.79-1.69) 1.13 (0.67-1.91)
b 
Multivariate HRs1 was adjusted for age  (continuous variable); weight change since 20 years old (loss of 10.0 kg or more, loss of 5.0-9.9 kg, change of less than ±
5.0 kg, gain of 5.0-9.9 kg, or gain of 10.0 kg or more); education (junior high school or less, high school, or college/university or higher); marital status (married or
unmarried); cigarette smoking (never smoker, past smoker, current smoker consuming 1-19 cigarettes per day, or current smoker consuming at least 20 cigarettes
per day); alcohol drinking (never drinker, past drinker, or current drinker); time spent walking per day (less than 1 hour, or 1hour or longer); sports and physical
exercise time per week (less than 1 hour, 1-2 hours, 3-4 hours, or 5 hours or longer); history of kidney disease (presence or absence); history of liver disease
(presence or absence).
c
 Multivariate HRs2 was excluded from multivariate HRs1 the 473 men who died within the 2 years after baseline.
Table 4.　Continued
a
 HR, hazard ratio; CI, confidence interval; BMI, body mass index.
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